Antifungal susceptibility of Malassezia pachydermatis biofilm

References

• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318–1322.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167–193.
   PubMed Web of Science ®Google Scholar
• Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006; 9: 588–594.
   PubMed Web of Science ®Google Scholar
• Tomlin KL, Malott RJ, Ramage G, et al. Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl Environ Microbiol 2005; 71: 5208–5218.
   PubMed Web of Science ®Google Scholar
• Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol 2012; 2012: 528521.
   PubMedGoogle Scholar
• Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004; 48: 3291–3297.
   PubMed Web of Science ®Google Scholar
• Chandra J, Zhou G, Ghannoum MA. Fungal biofilms and antimycotics. Curr Drug Targets 2005; 6: 887–894.
   Google Scholar
• Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryotic Cell 2005; 4: 633–638.
   PubMed Web of Science ®Google Scholar
• Xie Z, Thompson A, Kashleva H, Dongari-Bagtzoglou A. A quantitative real-time RT-PCR assay for mature C. albicans biofilms. BMC Microbiol 2011; 11: 93.
   PubMed Web of Science ®Google Scholar
• Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 185–190.
   PubMedGoogle Scholar
• Di Bonaventura G, Pompilio A, Picciani C, et al. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 2006; 50: 3269–3276.
   PubMed Web of Science ®Google Scholar
• Ramage G, Mowat E, Williams C, Ribot JLL. Yeast biofilms. In: Ashbee HR, Bignell EM (eds). Pathogenic Yeasts, The Yeast Handbook, Heidelberg: Springer, 2010: 121–144.
   Google Scholar
• Figueredo LA, Cafarchia C, Desantis S, Otranto D. Biofilm formation of Malassezia pachydermatis from dogs. Vet Microbiol 2012; 160: 126–131.
   Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385–5394.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, George T, Chandra J, Mukherjee PK, Ghan-noum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773–1780.
   PubMed Web of Science ®Google Scholar
• Cannizzo FT, Eraso E, Ezkurra PA, et al. Biofilm development by clinical isolates of Malassezia pachydermatis. Med Mycol 2007; 45: 357–361.
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Otranto D. The pathogenesis of Malassezia yeasts. Parassitologia 2008; 50: 65–67.
   Google Scholar
• Oliveira LC, Leite CA, Brilhante RS, Carvalho CB. Comparative study of the microbial profile from bilateral canine otitis externa. Can Vet J 2008; 49: 785–788.
   Google Scholar
• Larocco M, Dorenbaum A, Robinson A, Pickering LK. Recovery of Malassezia pachydermatis from eight infants in a neonatal intensive care nursery: clinical and laboratory features. Pediatr Infect Dis J 1988; 7: 398–401.
   PubMedGoogle Scholar
• Mickelsen PA, Viano-Paulson MC, Stevens DA, Diaz PS. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J Infect Dis 1988; 157: 1163–1168.
   PubMed Web of Science ®Google Scholar
• Welbel SF, McNeil MM, Pramanik A, et al. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit. Pediatr Infect Dis J 1994; 13: 104–108.
   PubMed Web of Science ®Google Scholar
• Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001; 90: 323–327.
   PubMed Web of Science ®Google Scholar
• Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006; 55: 999–1008.
   PubMed Web of Science ®Google Scholar
• Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996; 69: 337–355.
   PubMed Web of Science ®Google Scholar
• Guillot J, Guého E, Lesourd M, et al. Identification of Malassezia species. A practical approach. J Mycol Med 1996; 6: 103–111.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference methods for broth dilution susceptibility testing of yeast; approved standard, 2nd edn. Document M27-A2. Wayne, PA, 2002.
   Google Scholar
• Nascente PS, Meinerz ARM, Faria RO, et al. CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole. Braz J Microbiol 2009; 40: 222–226.
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions. Vet Microbiol 2012; 155: 395–398.
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Figueredo LA, Iatta R, et al. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Med Mycol 2012; 50: 795–801.
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Figueredo LA, Favuzzi V, et al. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol. Vet Microbiol 2012; 159: 536–540.
   Google Scholar
• Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 2004; 42: 3589–3593.
   PubMedGoogle Scholar
• Cantón E, Espinel-Ingroff A, Pemán J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther 2009; 7: 107–119.
   PubMed Web of Science ®Google Scholar
• Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008; 3: 1494–1500.
   PubMed Web of Science ®Google Scholar
• Ayres M, Ayres M Jr, Ayres DL, Santos AAS. BioEstat – Statistics applications on biomedical sciences. Belém-Pa: Ong Mamiraua, 2005.
   Google Scholar
• Perumal P, Mekala S, Chaffin WL. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents and Chemother 2007; 51: 2454–2463.
   PubMed Web of Science ®Google Scholar
• Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002; 46: 202–256.
   PubMed Web of Science ®Google Scholar
• White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704–1713.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135–138.
   PubMed Web of Science ®Google Scholar
• Davis LE, Cook G, Costerton JW. Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 2002; 8: 376–379.
   PubMedGoogle Scholar
• Conley J, Olson ME, Cook LS, et al. Biofilm formation by group A streptococci: is there a relationship with treatment failure?J Clin Microbiol 2003; 41: 4043–4048.
   Google Scholar
• Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10: 14–19.
   PubMed Web of Science ®Google Scholar
• Negre A, Bensignor E, Guillot J. Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. Vet Dermatol 2009; 20: 1–12.
   PubMed Web of Science ®Google Scholar
• Bond R. Superficial veterinary mycoses. Clin Dermatol 2010; 28: 226–236.
   PubMed Web of Science ®Google Scholar
• Rasmussen TB, Givskov M. Quorum sensing inhibitors: a bargain of effects. Microbiology 2006; 152: 895–904.
   PubMed Web of Science ®Google Scholar